| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |